ACLARIS THERAPEUTICS INC's ticker is and the CUSIP is 00461U905. A total of 4 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $374 | +189.9% | 54,700 | +337.6% | 0.00% | – |
| Q2 2023 | $129 | -88.1% | 12,500 | -90.6% | 0.00% | -100.0% |
| Q1 2023 | $1,080 | +26900.0% | 133,600 | +44433.3% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 300 | -78.6% | 0.00% | – |
| Q3 2022 | $22,000 | -83.7% | 1,400 | -85.6% | 0.00% | – |
| Q2 2022 | $135,000 | -57.8% | 9,700 | -47.8% | 0.00% | – |
| Q1 2022 | $320,000 | +661.9% | 18,600 | +541.4% | 0.00% | – |
| Q4 2021 | $42,000 | -85.3% | 2,900 | -82.5% | 0.00% | – |
| Q3 2021 | $285,000 | -2.1% | 16,600 | 0.0% | 0.00% | – |
| Q2 2021 | $291,000 | +315.7% | 16,600 | +59185.7% | 0.00% | – |
| Q1 2021 | $70,000 | +337.5% | 28 | +12.0% | 0.00% | – |
| Q4 2020 | $16,000 | +166.7% | 25 | -58.3% | 0.00% | – |
| Q1 2020 | $6,000 | -53.8% | 60 | -16.7% | 0.00% | – |
| Q4 2019 | $13,000 | +1200.0% | 72 | +2300.0% | 0.00% | – |
| Q1 2019 | $1,000 | -90.9% | 3 | -50.0% | 0.00% | – |
| Q2 2018 | $11,000 | -45.0% | 6 | -70.0% | 0.00% | -100.0% |
| Q4 2017 | $20,000 | – | 20 | +233.3% | 0.00% | – |
| Q1 2017 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 250,000 | $2,022,500 | 0.41% |
| GROUP ONE TRADING, L.P. | 73,200 | $592,188 | 0.00% |
| SIMPLEX TRADING, LLC | 133,600 | $1,080 | 0.00% |
| Worth Venture Partners, LLC | 25,600 | $1,280 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |